Code | 0826C | ||||||||||
MA number | EU/1/16/1102/001 | ||||||||||
Product Form: | plv ino 1x3,5 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Sun Pharmaceutical Industries Europe B.V. , Netherland | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Subcutaneous and intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 22.07.2016 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 12.10.2022 |